Viewing nowCombinationLevotitan Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
AhnGuk Pharmaceutical Co., Ltd.

MFDS item code 201606820 · Approved 2016.11.30 · Insurance code 650204740
Treatment of essential hypertension not controlled with monotherapy
This medication helps lower blood pressure more effectively by using both medications together when blood pressure in patients with essential hypertension is not sufficiently controlled by either amlodipine or telmisartan alone. It is used to manage blood pressure reliably, thus reducing the risk of cardiovascular diseases and preserving health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ○ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, and should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain medical conditions, such as severe liver impairment, patients with heart failure or heart problems, and patients with hypotension, among others. Patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, kidney problems, and the elderly should use this medication with caution. Side effects like dizziness or peripheral edema may occur frequently, and serious side effects may occur rarely, so if any abnormal symptoms arise, it is essential to consult a healthcare professional immediately. This medication should be avoided during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible, with a switch to alternative therapies. Due to the risk of hypotension, patients with fluid or salt deficiency should improve their condition before taking this medication and monitor their blood pressure closely during treatment. There is a risk of hyperkalemia, so regular monitoring of blood potassium levels is necessary, and caution is needed when used with potassium supplements or medications containing potassium. Patients with weakened kidney function should frequently check their kidney function and electrolyte status while taking this medication. This medication can interact with other antihypertensive agents or specific drugs, so patients must inform their healthcare provider of any other medications they are taking. Breastfeeding women should avoid taking this medication and it is not recommended for children or adolescents under 18 years of age. In case of overdose, hypotension, dizziness, and heart-related issues may arise; therefore, strict adherence to the prescribed dosage is crucial, and if any unusual symptoms occur, a visit to the hospital should be made immediately. This medication should be stored in a container that can block light and kept out of reach of children, and packaging should only be opened immediately prior to use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that can block light, at room temperature between 1°C and 30°C. This storage method helps maintain the medication's efficacy and safety.
This is a white and light gray, double-convex oval tablet.
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
AhnGuk Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.